| scholarly article | Q13442814 |
| P2093 | author name string | Takahiko Horiuchi | |
| Atsushi Tanaka | |||
| Hiroaki Niiro | |||
| Koichi Akashi | |||
| Chikako Kiyohara | |||
| Hiroki Mitoma | |||
| Hiroshi Tsukamoto | |||
| Yasutaka Kimoto | |||
| Yoshifumi Tada | |||
| Yojiro Arinobu | |||
| Naoyasu Ueda | |||
| Mitsuteru Akahoshi | |||
| Masahiro Ayano | |||
| Shun-ichiro Ohta | |||
| P2860 | cites work | Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis | Q81726575 |
| Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM | Q83504239 | ||
| Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis | Q84045856 | ||
| Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin | Q30482362 | ||
| Cellular localization of gene expression for progranulin | Q33180554 | ||
| Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis | Q33614747 | ||
| Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice | Q33615151 | ||
| Polymyositis and dermatomyositis (first of two parts) | Q33911013 | ||
| The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice | Q35014661 | ||
| Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis | Q35203303 | ||
| Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis | Q35549233 | ||
| Cytokine disturbances in systemic lupus erythematosus | Q35617573 | ||
| Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival | Q36527176 | ||
| Insights into the role of progranulin in immunity, infection, and inflammation | Q36534831 | ||
| Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity | Q36907736 | ||
| The granulin gene family: from cancer to dementia | Q37606400 | ||
| Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response | Q37784426 | ||
| Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls | Q37786515 | ||
| Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? | Q37817559 | ||
| Interstitial Lung Disease in Idiopathic Inflammatory Myopathy. | Q37937430 | ||
| Granulin is a soluble cofactor for toll-like receptor 9 signaling | Q38335862 | ||
| Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis | Q40499384 | ||
| Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment | Q40593461 | ||
| Progranulin is a mediator of the wound response | Q40678214 | ||
| Amyopathic dermatomyositis: a review | Q40870518 | ||
| PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue | Q42801261 | ||
| Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis | Q43055408 | ||
| Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases | Q43615292 | ||
| The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody | Q43638792 | ||
| Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis. | Q44049093 | ||
| Toll-like receptors promote inflammation in idiopathic inflammatory myopathies | Q45207411 | ||
| Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease | Q45773557 | ||
| IL-6-induced skeletal muscle atrophy | Q46172460 | ||
| Successful treatment of rapidly progressive interstitial pneumonia with autologous peripheral blood stem cell transplantation in a patient with dermatomyositis | Q47794620 | ||
| Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease. | Q51317487 | ||
| Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. | Q54635163 | ||
| KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis | Q62555846 | ||
| Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A | Q62735679 | ||
| Dermatomyositis | Q73313259 | ||
| Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease | Q73363557 | ||
| American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) | Q73445075 | ||
| KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases | Q73797332 | ||
| Serum KL-6 in adult patients with polymyositis and dermatomyositis | Q73976646 | ||
| Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? | Q77802015 | ||
| Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease | Q78489114 | ||
| Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process | Q79318117 | ||
| Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study | Q79796038 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | dermatomyositis | Q681160 |
| interstitial lung disease | Q1153419 | ||
| P304 | page(s) | 27 | |
| P577 | publication date | 2015-02-10 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis | |
| P478 | volume | 17 |
| Q99574672 | AST/ALT ratio as a predictor of mortality and exacerbations of PM/DM-ILD in 1 year-a retrospective cohort study with 522 cases |
| Q40179978 | Contribution of Progranulin to Protective Lung Immunity During Bacterial Pneumonia |
| Q40686335 | Progranulin Plays a Central Role in Host Defense during Sepsis by Promoting Macrophage Recruitment |
| Q86478450 | Serum progranulin irrelated with Breg cell levels, but elevated in RA patients, reflecting high disease activity |
| Q45861719 | Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study |
Search more.